P. D. Niedmann
University of Göttingen
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by P. D. Niedmann.
Clinical Biochemistry | 1997
Ekkehard Schütz; Eberhard Wieland; Andrea Hensel; P. D. Niedmann; Alexandra Dreiss; Victor W. Armstrong; Peter Schuff-Werner; Michael Oellerich
OBJECTIVE Despite the large body of evidence for a major role of neutrophils and oxidant stress, the exact pathogenesis of the early ischemia/reperfusion injury after cold preservation of the liver is not well understood. The potential benefit of an antioxidant on metabolic liver function during reperfusion has been demonstrated in several studies. MATERIALS AND METHODS We describe a cold storage/reperfusion damage model with isolated perfused pig livers, where the effects of neutrophils and idebenone, a recently developed benzoquinone antioxidant were studied. The integrity of sinusoidal endothelial cells (SEC) was estimated by hyaluronic acid concentration in perfusate and the expression of endothelial constitutive nitric oxide synthase (ecNOS) after reperfusion and compared to lipid peroxidation and antioxidant content. RESULTS Hyaluronic acid displayed the highest levels and ecNOS mRNA was most depressed in livers reperfused with neutrophils after 20 h cold storage; this was accompanied by an increase in lipid peroxidation (TBARS) and a breakdown of endogenous lipophilic antioxidants (alpha-tocopherol and coenzyme Q-10). These effects were attenuated, when neutrophils were excluded from reperfusion and almost completely abolished by the addition of 200 mumol/L idebenone. CONCLUSIONS These data suggest that a leukocyte-mediated damage based on reactive oxygen species markedly contributes to the reperfusion injury of SEC after cold preservation of the liver. Therefore, the presence of effective antioxidants in the early reperfusion phase may be beneficial for liver graft integrity.
Clinical Biochemistry | 2001
Eberhard Wieland; Maria Shipkova; Ekkehard Schütz; Felix Braun; P. D. Niedmann; Victor W. Armstrong; Burckhardt Ringe; Dobrin Svinarov; Michael Oellerich
OBJECTIVES Little is known about the effect of ischemia/reperfusion with xenogenic blood on function and gene expression of CYP3A4, the enzyme largely responsible for the metabolism of the immunosuppressants Cyclosporin A (CsA) and Tacrolimus. DESIGN AND METHODS In a pig liver perfusion model, we have compared the effect of perfusion (3 h) after 20 h cold storage, with either pig or human blood on CsA metabolism and CYP3A4-mRNA expression. mCYP3A4-mRNA was quantified by RT-PCR, CsA and its major metabolites AM1, AM9, AM4N by RP-HPLC. IL-6 served as inflammation marker, GLDH and ALT to estimate tissue damage. RESULTS Inflammatory response and tissue damage were more extensive during xenoperfusion. CYP3A4 expression decreased similarly during xenogenic and allogenic perfusion. CsA conversion to its metabolites was also comparable during xeno- and alloperfusion. CONCLUSION There is no evidence that during the early reperfusion period pig liver CYP3A4 is severely affected if the organ is xenoperfused with human blood in comparison with alloperfusion.
Transplantation Proceedings | 1998
Ekkehard Schütz; Maria Shipkova; Victor W. Armstrong; P. D. Niedmann; L Weber; B Tönshoff; K Pethig; T Wahlers; Felix Braun; B Ringe; Michael Oellerich
Clinical Chemistry | 1998
Ekkehard Schütz; Dobrin Svinarov; Maria Shipkova; P. D. Niedmann; Victor W. Armstrong; Eberhard Wieland; Michael Oellerich
Transplantation Proceedings | 2001
Maria Shipkova; Eberhard Wieland; Ekkehard Schütz; C Wiese; P. D. Niedmann; Michael Oellerich; Victor W. Armstrong
Transplantation Proceedings | 1998
Ekkehard Schütz; Victor W. Armstrong; Maria Shipkova; L Weber; P. D. Niedmann; T Lammersdorf; Manfred Wiesel; Alexander Mandelbaum; L.B Zimmerhackl; Otto Mehls; B Tönshoff; Michael Oellerich
Transplantation Proceedings | 1999
Maria Shipkova; Ekkehard Schütz; Victor W. Armstrong; P. D. Niedmann; Eberhard Wieland; Michael Oellerich
Therapeutic Drug Monitoring | 2000
Ekkehard Schütz; Maria Shipkova; Eberhard Wieland; P. D. Niedmann; Victor W. Armstrong; Michael Oellerich
Clinical Chemistry | 2001
Frank Streit; P. D. Niedmann; Maria Shipkova; Victor W. Armstrong; Michael Oellerich
Therapeutic Drug Monitoring | 1997
Victor W. Armstrong; Ekkehard Schütz; I. Meinecke; M. Andreeva; P. D. Niedmann; Lutz T. Weber; Timo Lamersdorf; Manfred Wiesel; A. Mandelbaum; Otto Mehls; Lothar Bernd Zimmerhackl; Burkhard Tönshoff; Michael Oellerich